Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Create Alert
Watchlist
Eris Lifesciences
₹1,571.60
+19.50 (1.26%)
1D
Manage alerts
Active alerts for Eris Lifesciences
ADD NEW ALERT
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
ScoutQuest .
2 weeks ago
Eris Lifesciences outlined focus on revenue, margins, acquisitions, and expansion into diabetes, injectables, and global markets. The company detailed capex, debt reduction plans, and expects improved profitability and debt ratios.
Zee Business .
4 weeks ago
Indian pharma exports remain resilient against potential US tariffs on branded drugs. Eris Lifesciences acquires 30% stake in Swiss Parenterals for Rs 4.23 billion.
The Hindu BusinessLine .
4 weeks ago
Cello World enters agreement to assign Cello Brand trademark for stationery and writing instruments, zero royalty. Dr. Reddy’s, Paras Defence among 10 stocks in focus on Nov 25.
ScoutQuest .
4 weeks ago
Eris Lifesciences approves acquisition of 30% stake in Swiss Parenterals for INR 423.3 cr via preferential shares. Swiss Parenterals' turnover grew from INR 220.8 cr to INR 351.1 cr over 3 years.
BSE .
1 month ago
Eris Lifesciences plans a board meeting on Nov 24, 2025 to discuss equity issuance via preferential issue. The issuance aims to acquire the remaining 30% stake in Swiss Parenterals Ltd, subject to approvals.
ScoutQuest .
1 month ago
Eris Lifesciences Ltd conducted its earnings call discussing financial performance.
ScoutQuest .
1 month ago
Eris Lifesciences aims for 12% revenue growth and capacity expansion by FY27.
ScoutQuest .
1 month ago
Eris Lifesciences' domestic branded formulations revenue grew 10% YoY in Q2 FY26. gSaxenda approval delay led to launch cancellation; FY26 revenue growth expected at 12%, EBITDA at 15%.
Livesquawk .
1 month ago
Eris Lifesciences Q2 revenue rises to ₹7.9B from ₹7.4B YoY.
NDTV Profit .
2 months ago
Healthcare FPIs saw record outflows of $690M in Sept, BSE Healthcare index fell 1.3%. Shree Gamesh Remedies dropped 12.5%, Eris Lifesciences 11.7%, Shilpa Medicare 10.9%.